Search results: Sage Journals

Restricted accessResearch articleFirst published January, 2017

The EDSS-Plus,an improved endpoint for disability progression in secondary progressive multiple sclerosis

Diego Cadavid, Jeffrey A Cohen, Mark S Freedman [...]

Multiple Sclerosis Journal

Restricted accessResearch articleFirst published October, 2022

Plasma glial fibrillary acidic protein and neurofilament light chain in relation to disability worsening in multiple sclerosis

Ayla Pauwels, Jeroen Van Schependom, Lindsay Devolder [...]

Multiple Sclerosis Journal

Open accessResearch articleFirst published October, 2020

Infratentorial and spinal cord lesions: Cumulative predictors of long-term disability?

Iris Dekker, Madeleine H Sombekke, Lisanne J Balk [...]

Multiple Sclerosis Journal

Free accessResearch articleFirst published March, 2016

Fludarabine add-on therapy in interferon-beta-treated patients with multiple sclerosis experiencing breakthrough disease

Steven J. Greenberg, Robert Zivadinov, Peterkin Lee-Kwen [...]

Therapeutic Advances in Neurological Disorders

Restricted accessResearch articleFirst published 2026

Accelerometry-derived activity fragmentation as a predictor of brain atrophy and disability progression in multiple sclerosis

Angeliki G Filippatou, Muraleetharan Sanjayan, Blake E Dewey [...]

Multiple Sclerosis Journal

Restricted accessResearch articleFirst published October, 2021

Oligoclonal IgM bands in the cerebrospinal fluid of patients with relapsing MS to inform long-term MS disability

Rocco Capuano, Irati Zubizarreta, Salut Alba-Arbalat [...]

Multiple Sclerosis Journal

Restricted accessResearch articleFirst published June, 2008

A Randomized Pilot Study of Naturopathic Medicine in Multiple Sclerosis

Lynne Shinto, Carlo Calabrese, Cynthia Morris [...]

Journal of Integrative and Complementary Medicine

Restricted accessOtherFirst published April, 2010

Atorvastatin Combined To Interferon to Verify the Efficacy (ACTIVE) in relapsing— remitting active multiple sclerosis patients: a longitudinal controlled trial of combination therapy

Roberta Lanzillo, Giuseppe Orefice, Mario Quarantelli [...]

Multiple Sclerosis Journal

Restricted accessResearch articleFirst published June 17, 2024

Co-supplementation of synbiotics and anti-inflammatory-antioxidant rich diet in patients with progressive forms of multiple sclerosis: A single-center,randomized clinical trial

Amir Reza Moravejolahkami, Ahmad Chitsaz, Akbar Hassanzadeh [...]

Mediterranean Journal of Nutrition and Metabolism

Restricted accessResearch articleFirst published April, 2017

Association of asymptomatic spinal cord lesions and atrophy with disability 5 years after a clinically isolated syndrome

WJ Brownlee, DR Altmann, P Alves Da Mota [...]

Multiple Sclerosis Journal

Restricted accessResearch articleFirst published January, 2017

The EDSS-Plus,an improved endpoint for disability progression in secondary progressive multiple sclerosis

Diego Cadavid, Jeffrey A Cohen, Mark S Freedman [...]

Multiple Sclerosis Journal

Restricted accessResearch articleFirst published October, 2022

Plasma glial fibrillary acidic protein and neurofilament light chain in relation to disability worsening in multiple sclerosis

Ayla Pauwels, Jeroen Van Schependom, Lindsay Devolder [...]

Multiple Sclerosis Journal

Open accessResearch articleFirst published October, 2020

Infratentorial and spinal cord lesions: Cumulative predictors of long-term disability?

Iris Dekker, Madeleine H Sombekke, Lisanne J Balk [...]

Multiple Sclerosis Journal

Free accessResearch articleFirst published March, 2016

Fludarabine add-on therapy in interferon-beta-treated patients with multiple sclerosis experiencing breakthrough disease

Steven J. Greenberg, Robert Zivadinov, Peterkin Lee-Kwen [...]

Therapeutic Advances in Neurological Disorders

Restricted accessResearch articleFirst published 2026

Accelerometry-derived activity fragmentation as a predictor of brain atrophy and disability progression in multiple sclerosis

Angeliki G Filippatou, Muraleetharan Sanjayan, Blake E Dewey [...]

Multiple Sclerosis Journal

Restricted accessResearch articleFirst published October, 2021

Oligoclonal IgM bands in the cerebrospinal fluid of patients with relapsing MS to inform long-term MS disability

Rocco Capuano, Irati Zubizarreta, Salut Alba-Arbalat [...]

Multiple Sclerosis Journal

Restricted accessResearch articleFirst published June, 2008

A Randomized Pilot Study of Naturopathic Medicine in Multiple Sclerosis

Lynne Shinto, Carlo Calabrese, Cynthia Morris [...]

Journal of Integrative and Complementary Medicine

Restricted accessOtherFirst published April, 2010

Atorvastatin Combined To Interferon to Verify the Efficacy (ACTIVE) in relapsing— remitting active multiple sclerosis patients: a longitudinal controlled trial of combination therapy

Roberta Lanzillo, Giuseppe Orefice, Mario Quarantelli [...]

Multiple Sclerosis Journal

Restricted accessResearch articleFirst published June 17, 2024

Co-supplementation of synbiotics and anti-inflammatory-antioxidant rich diet in patients with progressive forms of multiple sclerosis: A single-center,randomized clinical trial

Amir Reza Moravejolahkami, Ahmad Chitsaz, Akbar Hassanzadeh [...]

Mediterranean Journal of Nutrition and Metabolism

Restricted accessResearch articleFirst published April, 2017

Association of asymptomatic spinal cord lesions and atrophy with disability 5 years after a clinically isolated syndrome

WJ Brownlee, DR Altmann, P Alves Da Mota [...]

Multiple Sclerosis Journal